15 July 2016
From the Milky Way to the Solar System: Wnt's the Matter?
Organised by:
SCI's Biotechnology Group in partnership with the University of Westminster
University of Westminster
Registration Closed
This event is no longer available for registration.
Synopsis
Prostate cancer is the most common cancer in men. Convential therapies target androgen signalling, however, they provide limited survival benefits for patients. The Wnt signalling pathway induces expression of target genes through cell surface receptors. It was found that prostate cancer cell lines express high levels of Wnt-11, a non canonical member of the Wnt family.Programme
Day 1 - 15 July 2016
Event Schedule
- 13:00
- Event begins
Venue and Contact
University of Westminster
School of Life Sciences115 New Cavendish Street
London W1W 6UW
SCI Communications Team
Tel: +44 (0) 20 7598 1594
Email: communications@soci.org
Fees
This is a free event, no need to book. Please check this page for any updates or changes before attending the event.
Become an SCI Member and save on this and future events
See Membership OptionsSign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.
Partners
Additional Info
Related Events
- Cheminformatics for Drug Design: Data, Models and Tools, The Airspace Conference Centre, Imperial War Museyum, Duxford, UK, 12 October 2016
- Plugging the Antibiotics Gap: A Medicinal Chemist's Perspective, Alderley Park Conference Centre, Alderley Edge, Cheshire, UK, 16 November 2016
- Other Biotechnology Group Events
For more information, please contact:
Speaker
Dr Pinar Onganer, Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster